Copy

Microdose Psychedelic InsightsUniversal Ibogaine along with The Conscious Fund, ACS Pharmacology & Translational Science, are pleased to present The Ibogaine Conference: A Molecular Masterclass, on February 19-20th.
 

PRESENTED BY MICRODOSE

We're currently giving away 100 free tickets (first come, first serve)!
Join us at the two-day virtual conference featuring over 30 experts of the leading researchers in the therapeutic use of Ibogaine, a powerful psychedelic plant from Africa showing immense potential in the treatment of addiction.

The conference aims to raise awareness of the beneficial properties of this unique plant-derived medicine, to stimulate further research interest, medicalization, support advocacy in different contexts as well as discuss the use of ibogaine as a therapy for addiction, neurodegenerative disorders, as well as a catalyst for spiritual development. 

GET TICKETS NOW
Deborah Mash is one of the world's foremost experts on the hallucinogenic drug ibogaine. She is the CEO and Founder of DemeRx Inc., a clinical stage drug development company advancing ibogaine and its active metabolite noribogaine for the treatment of opioid use disorder. DemeRx has partnered with ATAI Life Sciences -- a global biotech platform with a special focus on psychedelic medicine -- to develop ibogaine for those suffering from opioid use disorder. 
Dr. Alberto Sola, Clear Sky Addiction Solution’s President
Clear Sky Addiction Solution’s President, Dr Sola is a thought leader in entheogenic treatment. He has the distinction of having treated more patients with ibogaine than any other person in the world and is head of operations at Clear Sky Recovery. Dr. Sola graduated from Universidad Anahuac. As the Medical Director of Amerimed, he opened four emergency hospitals for tourists in Puerto Vallarta, Cancun, and Cabo San Lucas.
Prof. Dr. Rafael dos Santos
Ph.D. in Pharmacology. Currently performs postdoctoral studies researching the effects of ayahuasca on depression and anxiety, ibogaine in alcoholic patients, and cannabidiol (CBD) in neuropsychiatric disorders.
Dan The Pharmacist Schneider
Advocate since my son died a drug-related death 22yrs ago. My story is told in the Netflix docuseries 'The Pharmacist". I am now building The Pharmacist's People's Lobby via my tunnelofhope.org and my Tunnel of hope non-profit Foundation. We want to be able to have large numbers of followers so we can influence politicians on new treatments, laws, and policies to reduce the Opioid and Addiction Pandemic.
VIEW MORE SPEAKERS
Connect with us on our other channels, too!
Facebook
Twitter
LinkedIn
Instagram
Pinterest
Website
Copyright © 2021 The Cannabis Community, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp